on BIOSYNEX (EPA:ALBIO)
BIOSYNEX SA: Declaration of Shares and Voting Rights
BIOSYNEX SA published on November 4, 2024 a regulatory update concerning the number of shares making up its share capital as well as the total voting rights. As of October 31, 2024, the company's capital consists of 10,760,870 shares. In addition, the total number of net voting rights amounts to 14,544,074.
This communication is part of the regulatory obligations provided for by Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Financial Markets Authority. BIOSYNEX, specializing in rapid health diagnostic solutions, continues to strengthen its market position by complying with financial transparency guidelines.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BIOSYNEX news